Livingston, NJ, United States of America

Nicholas A Paolella


Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1980-1990

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Nicholas A Paolella

Introduction

Nicholas A Paolella is a notable inventor based in Livingston, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as inhibitors for various biological processes. With a total of 3 patents to his name, Paolella's work has the potential to impact health and medicine positively.

Latest Patents

Among his latest patents, one includes "Azaindole derivatives useful as cholesterol biosynthesis inhibitors." This invention focuses on compounds characterized by a specific formula, where X represents the residue of an unsubstituted 6-membered aromatic ring containing three carbon atoms and one nitrogen atom. Another significant patent is for "1-Phenyl-pyrazole derivatives as glucagon inhibitors." This invention discloses certain 1-phenyl-pyrazole derivatives that exhibit pharmacological activity in animals and are useful as glucagon inhibiting agents. The majority of these compounds are synthesized through the cyclization of a phenyl hydrazine compound with a 1,1,3,3-tetra-C1-4-alkoxy-propane compound.

Career Highlights

Throughout his career, Nicholas A Paolella has worked with prominent companies in the pharmaceutical industry, including Sandoz GmbH and Sandoz Pharmaceutical Corporation. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Paolella has collaborated with several professionals in his field, including Paul L Anderson and Faizulla G Kathawala. These collaborations have likely enriched his research and development efforts, leading to the successful creation of his patented compounds.

Conclusion

Nicholas A Paolella's contributions to pharmaceutical innovation through his patents demonstrate his commitment to advancing medical science. His work in developing inhibitors for cholesterol biosynthesis and glucagon activity showcases the potential for significant health benefits.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…